Chronic Myelomonocytic Leukemia (CMML) Terminated Phase 1 Trials for Terameprocol (DB12226)

IndicationStatusPhase
DBCOND0037697 (Chronic Myelomonocytic Leukemia (CMML))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00664677Phase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaTreatment